ACS chemical neuroscience molecule spotlight on BMS-708163

Corey R. Hopkins

doi:10.1021/cn3000179

ACS chemical neuroscience molecule spotlight on BMS-708163

Corey R. Hopkins

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

Original language	English (US)
Pages (from-to)	149-150
Number of pages	2
Journal	ACS Chemical Neuroscience
Volume	3
Issue number	3
DOIs	https://doi.org/10.1021/cn3000179
State	Published - Mar 21 2012
Externally published	Yes

Keywords

Alzheimer's disease
GSI
amyloid hypothesis
gamma-secretase inhibitors

ASJC Scopus subject areas

Biochemistry
Physiology
Cognitive Neuroscience
Cell Biology

Access to Document

10.1021/cn3000179

Cite this

@article{4867608c7baa460ba7d9003efa93ad46,

title = "ACS chemical neuroscience molecule spotlight on BMS-708163",

abstract = "BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).",

keywords = "Alzheimer's disease, GSI, amyloid hypothesis, gamma-secretase inhibitors",

author = "Hopkins, {Corey R.}",

year = "2012",

month = mar,

day = "21",

doi = "10.1021/cn3000179",

language = "English (US)",

volume = "3",

pages = "149--150",

journal = "ACS Chemical Neuroscience",

issn = "1948-7193",

publisher = "American Chemical Society",

number = "3",

}

TY - JOUR

T1 - ACS chemical neuroscience molecule spotlight on BMS-708163

AU - Hopkins, Corey R.

PY - 2012/3/21

Y1 - 2012/3/21

N2 - BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

AB - BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

KW - Alzheimer's disease

KW - GSI

KW - amyloid hypothesis

KW - gamma-secretase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84858760430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858760430&partnerID=8YFLogxK

U2 - 10.1021/cn3000179

DO - 10.1021/cn3000179

M3 - Review article

C2 - 22860183

AN - SCOPUS:84858760430

SN - 1948-7193

VL - 3

SP - 149

EP - 150

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

IS - 3

ER -

ACS chemical neuroscience molecule spotlight on BMS-708163

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this